Recombinant Antigens for 2015-2022 Influenza Vaccine Strains

Seasonal flu is a common infectious disease of the respiratory tract caused by influenza virus. There are four types of influenza virus, influenza type A, B, C, and D. The A and B types are of most interest to the medical community because they are the culprits for seasonal epidemics. Occasionally, influenza A, like the A/California/04/09 (H1N1) and A/Hong Kong/1/1968 (H3N2), can even cause global pandemics.

Vaccination is the most effective way to prevent flu infection. Each year, several different flu strains are selected as vaccine strains based on surveillance data of the recent isolates, and the performance of the vaccines from the previous season. In recent decades, most vaccines are trivalent or quadrivalent, including one H1N1, one H3N2, and the Yamagata and Victoria type flu B.

Vaccine Strain

Sino Biological offers recombinant Flu antigen products under its ProVir® viral antigen collection. The product line covers Hemagglutinin (HA), Neuraminidase (NA), and Nucleoprotein (NP) proteins, from all WHO-recommended vaccine strains in recent years. These antigens can be used to analyze vaccine-induced antibody response. In addition, Sino Biological also develops a large collection of monoclonal antibodies against the flu antigens. These reagents can help facilitate relevant assay development.

 Year 2021-2022

 Year 2020-2021

  • A/Guangdong-Maonan/SWL1536/2019 (H1N1)
    Recommended for Egg-based (quadrivalent, trivalent) Vaccine
    HA: 40717-V08H
    NP: 40723-V08B
  • A/Hong Kong/2671/2019 (H3N2)
    Recommended for Egg-based (quadrivalent, trivalent) Vaccine
    HA: 40721-V08H
    NP: 40753-V08B
  • A/Hawaii/70/2019 (H1N1)
    Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine
    HA: 40717-V08H
    NP: 40724-V08B
  • A/Hong Kong/45/2019 (H3N2)
    Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine
    HA: 40765-V08H (Under Development)
    NP: 40754-V08B
  • B/Phuket/3073/2013
    Recommended for Egg-based, Cell- or recombinant-based (quadrivalent) Vaccine
    HA: 40498-V08B
    NA: 40502-V07B
    NP: 40500-V08B
  • B/Washington/02/2019
    Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine
    HA: 40722-V08H
    NA: 40790-V08B
    NP: 40755-V08B

 Year 2019-2020

 Year 2018-2019

 Year 2017-2018

 Year 2016-2017

 Year 2015-2016

Influenza Virus Antigen Information